Elliot J. MD Mba Sussman - 29 Oct 2025 Form 4 Insider Report for UNIVERSAL HEALTH SERVICES INC (UHS)

Role
Director
Signature
/s/ Elliot J. Sussman, M.D.
Issuer symbol
UHS
Transactions as of
29 Oct 2025
Net transactions value
-$217,939
Form type
4
Filing time
30 Oct 2025, 16:23:17 UTC
Previous filing
15 May 2025
Next filing
13 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SUSSMAN ELLIOT J MD MBA Director THE VILLAGES HEALTH, 3619 KIESSEL ROAD, THE VILLAGES /s/ Elliot J. Sussman, M.D. 30 Oct 2025 0001181000

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UHS Class B Common Stock Options Exercise $347,000 +2,500 +41% $138.80 8,613 29 Oct 2025 Direct
transaction UHS Class B Common Stock Tax liability $347,140 -1,535 -18% $226.15 7,078 29 Oct 2025 Direct
transaction UHS Class B Common Stock Sale $217,799 -965 -14% $225.70 6,113 29 Oct 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UHS Option To Purchase Class B Common Stock Options Exercise $0 -2,500 -50% $0.000000 2,500 29 Oct 2025 Class B Common Stock 2,500 $138.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.38 to $225.80, inclusive. The reporting person undertakes to provide Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1.
F2 Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.